RAC 2.92% $1.94 race oncology ltd

Ann: Compelling Preclinical Breast Cancer Results, page-74

  1. 917 Posts.
    lightbulb Created with Sketch. 228
    More than the magic numbers for buyout.. I really excited to see Bisantrene get to patients as quickly as possible. Pleasing to see new trials still showing promise aligning with historic info/trails which will hopefully see the expedited progressing of Bisantrene to market and patients who will benefit not only from the anti cancer properties but the reduction in longer term heart problems which claim the lives of those that survive the current anti-cancer treatments.

    Well done Race team, keep up the great work!
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.94
Change
0.055(2.92%)
Mkt cap ! $330.4M
Open High Low Value Volume
$1.89 $1.96 $1.85 $333.0K 174.5K

Buyers (Bids)

No. Vol. Price($)
1 3105 $1.94
 

Sellers (Offers)

Price($) Vol. No.
$1.95 7574 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.